Answer
No, the safety and efficacy of rasagiline tartrate in children and adolescents have not been established, and there is no relevant paediatric use for Parkinson’s disease.
Sources for this answer
- Rasagiline Milpharm 1 mg tabletsAurobindo Pharma - Milpharm Ltd. · emc · SmPC §4.2 Posology and method of administration · Version 4Document updated
Sources checked